BRIEF published on 02/19/2025 at 22:10, 1 year 8 months ago Bausch Health Reports Strong Financial Performance in 2024 Adjusted EBITDA Revenue Growth Financial Performance Bausch Health 2024 Results
PRESS RELEASE published on 02/19/2025 at 22:05, 1 year 8 months ago Bausch Health Announces Fourth Quarter and Full-Year 2024 Results Bausch Health Companies Inc. announces strong Q4 and full-year 2024 financial results, achieving revenue growth in all segments and exceeding adjusted EBITDA guidance Financial Results Adjusted EBITDA Revenue Growth Bausch Health Q4 2024
BRIEF published on 02/14/2025 at 14:05, 1 year 8 months ago Bausch Health participera à la conférence financière de JP Morgan Webcast Soins De Santé Bausch Santé Pharmaceutique Conférence Sur Les Finances
BRIEF published on 02/14/2025 at 14:05, 1 year 8 months ago Bausch Health to Attend J.P. Morgan Finance Conference Healthcare Pharmaceutical Webcast Bausch Health Finance Conference
PRESS RELEASE published on 02/14/2025 at 14:00, 1 year 8 months ago Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference Bausch Health Companies Inc. to participate in 2025 J.P. Morgan Global Leveraged Finance Conference on February 24. Webcast available on Investor Relations section of Bausch Health's website Investor Relations Webcast Conference Bausch Health J.P. Morgan
BRIEF published on 02/10/2025 at 14:05, 1 year 9 months ago Bausch Health Launches 2025 Salix GI Health Scholars Program Salix Pharmaceuticals Bausch Health Higher Education GI Diseases Scholarship Program
BRIEF published on 02/10/2025 at 14:05, 1 year 9 months ago Bausch Health lance le programme de bourses d'études Salix GI Health 2025 Bausch Santé Enseignement Supérieur Programme De Bourses D'études Produits Pharmaceutiques Salix Maladies Gastro-intestinales
PRESS RELEASE published on 02/10/2025 at 14:00, 1 year 9 months ago Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program Bausch Health and Salix Pharmaceuticals launch 2025 Salix Gastrointestinal Health Scholars Program, offering scholarships for students living with GI diseases. Application deadline on May 5, 2025 Salix Pharmaceuticals Bausch Health Scholarships GI Diseases 2025
BRIEF published on 02/06/2025 at 13:10, 1 year 9 months ago Bausch Health Decides Against Sale of Bausch + Lomb Financial Performance Bausch Health Liability Management Bausch + Lomb Sale Decision
BRIEF published on 02/06/2025 at 13:10, 1 year 9 months ago Bausch Health décide de ne pas vendre Bausch + Lomb Performance Financière Bausch Santé Bausch + Lomb Décision De Vente Gestion De La Responsabilité
Published on 11/11/2026 at 10:30, 2 hours 25 minutes ago Temas Engages Arcstone Canada for Capital Markets Advisory and Investor-Communications Services
Published on 11/11/2026 at 03:30, 9 hours 25 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 12 hours 15 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 13 hours 25 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 13 hours 55 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 12:05, 50 minutes ago H.I.G. Capital Signs Definitive Agreement to Acquire Majority Stake in go asia
Published on 11/11/2026 at 12:05, 50 minutes ago EYKON brings digital revenue metering into the digital substation
Published on 11/11/2026 at 11:46, 1 hour 9 minutes ago ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/11/2026 at 11:18, 1 hour 37 minutes ago Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 11/11/2026 at 11:11, 1 hour 44 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA intends to notify a Restructuring Project under the StaRUG
Published on 11/10/2026 at 18:00, 18 hours 55 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 19 hours 10 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 19 hours 20 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 19 hours 23 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
